In mice inoculated with PDPN-expressing B16F10 melanoma cells, CLEC2 depletion by anti-CLEC2 mAb 2A2B10 injection reduced plasma levels of inflammatory cytokines and lung metastasis, resulting in prolonged survival compared to control mice (127). The gene discussed is PDPN; the disease is melanoma.